Hunan Jingfeng Pharmaceutical (000908) — Tangible Net Worth Ratio

Latest as of September 2023: -27.9%

Hunan Jingfeng Pharmaceutical (000908) has a Tangible Net Worth Ratio of -27.9% as of September 2023. This metric is calculated by deducting intangible assets (CN¥239.93 Million) from net assets (CN¥187.65 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Hunan Jingfeng Pharmaceutical to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

-27.9%
Tangible equity / total equity

Net Assets (Equity)

CN¥187.65 Million
CNY

Intangible Assets

CN¥239.93 Million
Goodwill, patents, brand value

Total Assets

CN¥1.44 Billion
CNY

Hunan Jingfeng Pharmaceutical Tangible Net Worth Ratio (1995–2022)

This chart shows how Hunan Jingfeng Pharmaceutical's Tangible Net Worth Ratio has changed across 27 annual periods from 1995 to 2022. As of September 2023, the ratio stands at -27.9%, reflecting net assets of CN¥187.65 Million with intangible assets of CN¥239.93 Million CNY. See operational self-sufficiency of Hunan Jingfeng Pharmaceutical to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Hunan Jingfeng Pharmaceutical (1995–2022)

The table below presents the year-by-year Tangible Net Worth Ratio for Hunan Jingfeng Pharmaceutical from 1995 to 2022, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 000908 market cap.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2022 4.9% CN¥214.83 Million CN¥204.36 Million CN¥1.47 Billion ▼ -30.9 pp
2021 35.8% CN¥327.73 Million CN¥210.44 Million CN¥1.79 Billion ▼ -25.9 pp
2020 61.6% CN¥638.18 Million CN¥244.78 Million CN¥2.69 Billion ▼ -19.5 pp
2019 81.2% CN¥1.94 Billion CN¥365.23 Million CN¥4.35 Billion ▼ -6.6 pp
2018 87.8% CN¥2.86 Billion CN¥348.18 Million CN¥5.23 Billion ▼ -2.6 pp
2017 90.4% CN¥2.60 Billion CN¥248.53 Million CN¥4.87 Billion ▼ -3.3 pp
2016 93.8% CN¥2.61 Billion CN¥162.41 Million CN¥5.13 Billion ▼ -3.1 pp
2015 96.8% CN¥2.25 Billion CN¥70.87 Million CN¥3.44 Billion ▼ -0.2 pp
2014 97.0% CN¥994.04 Million CN¥29.58 Million CN¥1.91 Billion ▲ +578.3 pp
2013 -481.3% CN¥5.31 Million CN¥30.86 Million CN¥336.78 Million ▲ +6828.5 pp
2011 -7309.7% CN¥790.82K CN¥58.60 Million CN¥421.45 Million ▼ -7331.1 pp
2010 21.4% CN¥57.85 Million CN¥45.46 Million CN¥471.37 Million ▲ +240.3 pp
2009 -218.9% CN¥100.67 Million CN¥321.08 Million CN¥784.81 Million ▼ -213.8 pp
2008 -5.2% CN¥338.64 Million CN¥356.09 Million CN¥989.24 Million ▼ -80.4 pp
2007 75.3% CN¥336.95 Million CN¥83.34 Million CN¥814.38 Million ▲ +6.6 pp
2006 68.7% CN¥336.40 Million CN¥105.44 Million CN¥822.47 Million ▼ -3.4 pp
2005 72.0% CN¥329.66 Million CN¥92.21 Million CN¥840.14 Million ▼ -0.9 pp
2004 73.0% CN¥339.45 Million CN¥91.75 Million CN¥889.56 Million ▼ -2.4 pp
2003 75.4% CN¥419.38 Million CN¥103.09 Million CN¥983.02 Million ▼ -3.7 pp
2002 79.1% CN¥522.69 Million CN¥109.08 Million CN¥866.67 Million ▼ -12.6 pp
2001 91.7% CN¥498.41 Million CN¥41.44 Million CN¥620.88 Million ▲ +1.5 pp
2000 90.2% CN¥500.54 Million CN¥49.11 Million CN¥697.92 Million ▼ -0.8 pp
1999 91.0% CN¥485.43 Million CN¥43.82 Million CN¥691.94 Million ▼ -3.0 pp
1998 94.0% CN¥400.62 Million CN¥24.01 Million CN¥473.15 Million ▲ +6.7 pp
1997 87.3% CN¥86.51 Million CN¥11.01 Million CN¥132.21 Million ▼ -5.5 pp
1996 92.8% CN¥60.83 Million CN¥4.40 Million CN¥131.54 Million ▲ +2.9 pp
1995 89.9% CN¥30.79 Million CN¥3.12 Million CN¥66.33 Million
pp = percentage points